morphosys ag (MOR:Xetra)
Chief Development Officer and Member of Management Board, Morphosys AG
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
As of Fiscal Year 2014
Dr. Arndt Schottelius serves as the Chief Development Officer of MorphoSys UK Ltd. Dr. Schottelius has been the Chief Development Officer and a Member of Management Board at Morphosys AG since December 29, 2008. He is responsible for coordinating the Group's expanding therapeutic antibody development activities including pre-clinical and clinical drug development. He was employed at Genentech Inc., South San Francisco, where he served as a Director of Immunology, Tissue ...
Lena-Christ-Strasse 48Phone: 49 8989 9270
Martinsried, Bavaria 82152
Fax: 49 89 8992 7222
Board Members Memberships*There is no Board Members Memberships data available.
Education*There is no Education data available.
|Daniel M. Junius||Chief Executive Officer, President and Director|
|Clay B. Siegall Ph.D.||Co-Founder, Chairman, Chief Executive Officer and President|
Seattle Genetics, Inc.
|John W. Varian||Chief Executive Officer and Director|
|Jan G. J. van de Winkel Ph.D.||Co-Founder, Chief Executive Officer and President|
|Edwin Moses Ph.D.||Chief Executive Officer, Director and Member of Research & Development Committee|
|--||Compensation as of Fiscal Year 2014.|